These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2417773)

  • 21. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug therapy and the most common drugs for childhood psychiatric disorders].
    Puustjärvi A; Raunio H; Lecklin A; Kumpulainen K
    Duodecim; 2016; 132(10):943-50. PubMed ID: 27382830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy for mental health problems in people with intellectual disability.
    Ji NY; Findling RL
    Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
    Walkup JT; Scahill LD; Riddle MA
    Adv Neurol; 1995; 65():259-72. PubMed ID: 7872144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 2).
    McDaniel KD
    Clin Pediatr (Phila); 1986 Mar; 25(3):143-6. PubMed ID: 2868821
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.
    Aman MG; Marks RE; Turbott SH; Wilsher CP; Merry SN
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):246-56. PubMed ID: 2016229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    Weller EB; Rowan A; Elia J; Weller RA
    J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beneficial effect of methylphenidate in ADHD with comorbid separation anxiety.
    Golubchik P; Golubchik L; Sever JM; Weizman A
    Int Clin Psychopharmacol; 2014 Sep; 29(5):274-8. PubMed ID: 24743562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(4):1-2, 5-7. PubMed ID: 11768409
    [No Abstract]   [Full Text] [Related]  

  • 31. Broader clinical considerations in child psychopharmacology practice.
    Safer DJ
    Compr Psychiatry; 1983; 24(6):567-73. PubMed ID: 6140125
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological management of treatment-induced insomnia in ADHD.
    Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders--a case series.
    Ingrassia A; Turk J
    Eur Child Adolesc Psychiatry; 2005 Feb; 14(1):34-40. PubMed ID: 15756514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can methylphenidate facilitate sleep in children with attention deficit hyperactivity disorder?
    Jerome L
    J Child Adolesc Psychopharmacol; 2001; 11(1):109. PubMed ID: 11322740
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
    Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic treatment of pediatric insomnia.
    Owens JA; Moturi S
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):1001-16. PubMed ID: 19836701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggression and disruptive behavior disorders in children and adolescents.
    Turgay A
    Expert Rev Neurother; 2004 Jul; 4(4):623-32. PubMed ID: 15853581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs in management of minimal brain dysfunction.
    Millichap JG
    Ann N Y Acad Sci; 1973 Feb; 205():321-34. PubMed ID: 4144050
    [No Abstract]   [Full Text] [Related]  

  • 39. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.
    Biederman J; Newcorn J; Sprich S
    Am J Psychiatry; 1991 May; 148(5):564-77. PubMed ID: 2018156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conduct disorder in referred children and adolescents: clinical and therapeutic issues.
    Masi G; Milone A; Manfredi A; Pari C; Paziente A; Millepiedi S
    Compr Psychiatry; 2008; 49(2):146-53. PubMed ID: 18243886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.